Overview
This study evaluates long-term safety and effectiveness of Growtropin®-II treatment in children with short stature.
Eligibility
Inclusion Criteria:
- Children with short stature by growth hormone deficiency(GHD) or idiopathic short stature (ISS) or turner's syndrome(TS) or small for gestational age(SGA)
- Children who has official height record at least 6 months prior
Exclusion Criteria:
- Children with Epiphyseal closure